DMCC SPECIALITY CHEMICALS LIMITED Q4 FY25 results deck summary

Results deck of 7 May 2025, summarised by AI from the filing.

Q4 FY25 revenue ₹125.22 cr, up 49.14% Y-o-Y, but EBITDA margin fell to 12.39% on sharp sulphur price rise.

Key takeaways

1. Q4 revenue Consolidated revenue ₹125.22 cr (Q4 FY24: ₹83.96 cr, +49.14%; Q3 FY25: ₹118.04 cr, +6.08%).
2. Margin decline EBITDA margin fell to 12.39% in Q4 FY25 from 15.30% in Q3 FY25, a decline of 291 bps.
3. Volume growth Revenue growth driven by increased volumes and modest improvement in realisations, reflecting steady demand across key segments.
4. Sulphur costs Profitability impacted by sharp rise in sulphur prices; speciality and export markets experienced lag in price adjustments.

Original filing on BSE

DMCC SPECIALITY CHEMICALS LIMITED Q1 FY27 results

As filed: Revenue ₹253 cr (+99% year on year), EBITDA ₹34.1 cr (+101% year on year), PAT ₹20.4 cr (+155% year on year), EBITDA margin 13.5% (+10 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹178 cr (+42% year on year), EBITDA ₹17.7 cr (+18% year on year), PAT ₹7.7 cr (+28% year on year), EBITDA margin 10.0% (−204 bps). Score 57 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 204 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −24.1% in 28 days (Nifty 500: −0.1%).
• Q3 FY26: Revenue ₹151 cr (+28% year on year), EBITDA ₹14.7 cr (−18% year on year), PAT ₹6.2 cr (−23% year on year), EBITDA margin 9.8% (−550 bps). Score 38 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 550 bps year on year. Share price after the results: −1.5% in 28 days (Nifty 500: −4.1%).
• Q2 FY26: Revenue ₹126 cr (+22% year on year), EBITDA ₹14.0 cr (−13% year on year), PAT ₹6.0 cr (0% year on year), EBITDA margin 11.1% (−442 bps). Score 36 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 442 bps year on year. Profit fell 25% from last quarter. Share price after the results: −8.2% in 30 days (Nifty 500: −0.2%).
• Q1 FY26: Revenue ₹127 cr (+49% year on year), EBITDA ₹17.0 cr (+89% year on year), PAT ₹8.0 cr (+300% year on year), EBITDA margin 13.4% (+280 bps). Score 70 of 100, Above trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 280 bps year on year. Share price after the results: +3.4% in 29 days (Nifty 500: +0.6%).
• Q4 FY25: Revenue ₹125 cr (+49% year on year), EBITDA ₹15.0 cr (+88% year on year), PAT ₹6.0 cr (0% year on year), EBITDA margin 12.0% (+248 bps). Score 64 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 248 bps year on year. Profit fell 25% from last quarter. Share price after the results: −8.5% in 30 days (Nifty 500: +3.3%).
• Q3 FY25: Revenue ₹118 cr (+46% year on year), EBITDA ₹18.0 cr (+157% year on year), PAT ₹8.0 cr, EBITDA margin 15.3% (+661 bps). Score 80 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it. EBITDA margin rose 661 bps year on year. Tax rate 36%. Revenue rose ₹37.0 cr on a year ago, more than the ₹9.0 cr it added the year before.
• Q2 FY25: Revenue ₹103 cr (+34% year on year), EBITDA ₹16.0 cr (+60% year on year), PAT ₹6.0 cr (+200% year on year), EBITDA margin 15.5% (+255 bps). Score 94 of 100, Above trend. EBITDA margin rose 255 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

DMCC SPECIALITY CHEMICALS LIMITED earnings call, investor presentation and press release summaries

• Q4 FY26: Earnings call (19 May 2026)
• Q2 FY26: Earnings call (12 Nov 2025)
• Q4 FY25: Earnings call (8 May 2025), Results deck (7 May 2025)